Theriva Biologics, Inc. (TOVX) stock
TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.14+0.00 (0.00%)
Close on Nov 17, 2026Market cap $6.42MP/E –Yield –
Theriva Biologics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Theriva Biologics's total debt was $63.00K at Dec 31, 2023. For fiscal 2023 it was $63.00K, up 10.5% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $63.00K | +10.5% |
| FY2022 | Dec 31, 2022 | $57.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $63.00K | +10.5% |
| Q3 FY2023 | Sep 30, 2023 | $65.00K | +25.0% |
| Q2 FY2023 | Jun 30, 2023 | $67.00K | +19.6% |
| Q1 FY2023 | Mar 31, 2023 | $66.00K | -2.9% |
| Q4 FY2022 | Dec 31, 2022 | $57.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $52.00K | – |
| Q2 FY2022 | Jun 30, 2022 | $56.00K | – |
| Q1 FY2022 | Mar 31, 2022 | $68.00K | – |
See a number that looks wrong?